Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 7 - Drugs for disorders of the blood or the extracellular fluid
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
06/2012
06/13/2012CN101721612B Chinese medicinal composition for raising leucocytes and preparation method and application thereof
06/13/2012CN101607003B High-efficiency extraction method of effective ingredients in golden camellia tea and application thereof in cigarette preparation
06/13/2012CN101280001B Preparation of human SDF-1 alpha, human SDF-1 alpha obtained therefrom and use thereof
06/13/2012CN101208334B Novel cyclic amines
06/12/2012US8198286 Sodium channel blockers
06/12/2012US8198272 Triazolium salts as PAR1 inhibitors, production thereof, and use as medicaments
06/12/2012US8198267 Substituted oxazolidinones and their use
06/12/2012US8198243 Resuscitation fluid
06/12/2012US8198030 Recombinant platelet collagen receptor glycoprotein VI and its pharmaceutical use
06/12/2012US8197848 Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors
06/12/2012US8197839 A miniature coated tablet or covered rod implant; smaller size and larger payloads than immediate release tablets; veterinary medicine
06/12/2012US8197813 Human antibodies that bind human TNFα
06/12/2012CA2647596C Pyrrolo- and thiazolo-pyridine compounds as hif modulators
06/07/2012WO2012075184A2 Cell lines that secrete anti-angiogenic antibody-scaffolds and soluble receptors and uses thereof
06/07/2012WO2012074469A1 New ikach blockers
06/07/2012WO2012074068A1 Method for producing hematopoietic stem cells using pyrazole compound
06/07/2012WO2012073891A1 Transfusion preparation
06/07/2012WO2012073593A1 Manufacturing method for dried earthworm powder
06/07/2012WO2012072824A1 Pharmaceutical compositions, dosage forms and new forms of the compound of formula (i), and methods of use thereof
06/07/2012WO2012071612A1 Treatment of jak2-mediated conditions
06/07/2012WO2012071611A1 Histone inhibition
06/07/2012WO2012051339A3 Methods and compositions for treating respiratory conditions using platelet enriched plasma
06/07/2012WO2012037283A3 Admimistration of sns neuroprotective agents to promote hematopoietic regeration
06/07/2012US20120142760 Compositions and methods for regulated protein expression in gut
06/07/2012US20120142744 Novel complexes of fatty acid esters of polyhydroxyalkanes and pyridine carboxy derivatives
06/07/2012US20120142740 Novel alkene derivatives as sphingosine 1-phosphate (s1p) receptor modulators
06/07/2012US20120142732 Heteroaryls and uses thereof
06/07/2012US20120142716 4-pyrimidinesulfamide derivative
06/07/2012US20120142694 Substituted 4-hydroxypyrimidine-5-carboxamides
06/07/2012US20120142692 Antifolate combinations
06/07/2012US20120142690 Substituted piperidines
06/07/2012US20120142689 Serotonin reuptake inhibitors
06/07/2012US20120142685 Organic compounds
06/07/2012US20120142683 Pyrimidine substituted purine compounds as kinase (s) inhibitors
06/07/2012US20120142680 Heteroalkyl linked pyrimidine derivatives
06/07/2012US20120142677 Pyrrolidine Compounds Which Modulate The CB2 Receptor
06/07/2012US20120142671 Benzamides and nicotinamides as syk modulators
06/07/2012US20120142666 Azetidine 2-Carboxamide Derivatives Which Modulate The CB2 Receptor
06/07/2012US20120142664 Novel benzyl azetidine derivatives as sphingosine 1-phosphate (s1p) receptor modulators
06/07/2012US20120142662 Novel azetidine derivatives as sphingosine 1-phosphate (s1p) receptor modulators
06/07/2012US20120142661 Novel oxime azetidine derivatives as sphingosine 1-phosphate (s1p) receptor modulators
06/07/2012US20120142659 Compounds and their use as ikach blockers
06/07/2012US20120142645 Neuroactive steroid compositions and methods of use for lowering cholesterol
06/07/2012US20120142642 Novel oxime derivatives as sphingosine 1-phosphate (s1p) receptor modulators
06/07/2012US20120142620 Core 2 glcnac-t inhibitors
06/07/2012US20120142593 Factor VIII Variants and Methods of Use
06/07/2012US20120142590 Methods and Compounds Regulating the Erythroid Response to Iron Deficiency
06/07/2012US20120142589 Tissue-protective cytokines for the protection, restoration and enhancement of responsive cells, tissues and organs
06/07/2012US20120141581 Capsule and powder formulations containing lanthanum compounds
06/07/2012US20120141573 Cell Lines That Secrete Anti-Angiogenic Antibody-Scaffolds and Soluble Receptors and Uses Thereof
06/07/2012US20120141562 Cell coated implantable device
06/07/2012US20120141558 Alginate-based nanofibers and related scaffolds
06/07/2012US20120141500 Antibodies Against Human Angiopoietin 2
06/07/2012US20120141468 Maintenance of platelet inhibition during antiplatelet therapy
06/07/2012US20120141466 Composition and method for treatment of reperfusion injury and tissue damage
06/07/2012US20120141449 Albumin Fusion Proteins
06/07/2012US20120141446 Oral Nutritional Supplement Delivery System
06/07/2012US20120141440 Foamyvirus vectors and methods of use
06/07/2012US20120141434 Methods for Selecting Expanded Stem Cell Populations
06/07/2012US20120141415 Albumin Fusion Proteins
06/07/2012US20120141412 Methods of treating idiopathic thrombocytopenic purpura with compositions comprising extracts of astragalus membranaceus
06/07/2012US20120141411 Uses of IL-174 Antagonists for Inhibiting A Th2 Immune Response
06/07/2012US20120138506 Methods of treatment and pharmaceutical composition
06/07/2012CA2819642A1 Histone inhibition
06/07/2012CA2819560A1 Treatment of jak2-mediated conditions
06/07/2012CA2819212A1 Infusion preparation
06/07/2012CA2804129A1 Manufacturing method for dried earthworm powder
06/06/2012EP2460806A1 Nitrogen-containing spiro-ring compound and medicinal use of same
06/06/2012EP2460520A1 Methods for dosing an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapy
06/06/2012EP2459555A1 Processes for crystallization of rivaroxaban
06/06/2012EP2459507A1 Use of erythritol for the prevention or treatment of hypertension
06/06/2012EP2459193A1 Otamixaban for treatment of elderly and renal impaired non-st elevation myocardial infarction patients
06/06/2012EP1548024B1 Pyrazole derivatives, medicinal composition containing the same, medicinal use thereof, and intermediate for production thereof
06/06/2012CN1984682B Solid medicinal preparation
06/06/2012CN102485748A Oligopeptides with targeting thrombolytic activity, preparation method thereof, and application thereof
06/06/2012CN102485747A Oligopeptides with targeting thrombolytic activity, preparation method and application thereof
06/06/2012CN102485746A Oligopeptides having target-oriented thrombolytic activity and their preparation method and application
06/06/2012CN102485745A Thrombolytic oligopeptides, preparation method and application thereof
06/06/2012CN102485744A Thrombolytic oligopeptide compound, its preparation method and application
06/06/2012CN102485741A Methyl reduced oleanane triterpenoid, its preparation method and application
06/06/2012CN102485724A Substituted thiazolyl pyrazolo pyridine compound and medical purpose thereof
06/06/2012CN102485260A Ointment composed of radix astragali and garden burnet
06/06/2012CN102485251A Pharmaceutical composition for treating functional uterine bleeding
06/06/2012CN102485232A Medicinal composition containing decitabine
06/06/2012CN102485222A Novel purpose of 3-methyl-1-phenyl-2-pyrazoline-5-ketone
06/06/2012CN102485218A Clopidogrel hydrogen sulfate tablet and preparation method thereof
06/06/2012CN102210669B Application of salvia extract in treating septicemia
06/06/2012CN101942040B Method for removing oversulfated chondroitin sulfate in heparin sodium
06/06/2012CN101940721B Traditional Chinese medicine for treating metrorrhagia and metrostaxis, gastrointestinal hemorrhage and traumatic hemorrhage and preparation method thereof
06/06/2012CN101940708B Traditional Chinese medicinal preparation for curing malignant pleural effusion
06/06/2012CN101843891B Blood tonifying composition
06/06/2012CN101785856B Stably isoosmotic desmoteplase alpha1 or mutant preparation thereof
06/06/2012CN101748110B Desmoteplase alpha 1 mutant
06/06/2012CN101690548B Method for producing feed additive for preventing and curing pig anemia
06/06/2012CN101560145B Method for separating chrysophanol and physcion by silica-gel column chromatography
06/06/2012CN101544693B Recombined extrasin alpha 1 two-strand body protein and preparation method thereof
06/06/2012CN101406603B Chinese herbal compound for treating gynaecologic metrorrhagia disease
06/06/2012CN101190942B Compound with thrombus dissolving activity and its preparation method and application
06/06/2012CN101190940B Polypeptide with target antithrombotic activity and its preparation method and application
06/05/2012US8193166 Epimerized derivatives of K5 polysaccharide with a very high degree of sulfation
1 ... 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 ... 671